Skip to main navigation Skip to search Skip to main content

Erratum: Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response (Immunity (2021) 54(2) (291–307.e7), (S1074761320305410), (10.1016/j.immuni.2020.12.013))

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademic

20 Downloads (Pure)

Abstract

(Immunity 54, 291–307.e1–e7; February 9, 2021) In the originally published article, author Feng Q. HeFeng's name appeared as “Feng Q He.” This has now been updated to “Feng Q. HeFeng.”
Original languageEnglish
Pages (from-to)2137
Number of pages1
JournalImmunity
Volume58
Issue number8
Early online date2025
DOIs
Publication statusPublished - 12 Aug 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Erratum: Induction of IL-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response (Immunity (2021) 54(2) (291–307.e7), (S1074761320305410), (10.1016/j.immuni.2020.12.013))'. Together they form a unique fingerprint.

Cite this